Format
Sort by

Send to:

Choose Destination

Results: 4

1.

Dolutegravir versus raltegravir in antiretroviral-experienced, integrase-inhibitor-naive adults with HIV: week 48 results from the randomised, double-blind, non-inferiority SAILING study.

Cahn P, Pozniak AL, Mingrone H, Shuldyakov A, Brites C, Andrade-Villanueva JF, Richmond G, Buendia CB, Fourie J, Ramgopal M, Hagins D, Felizarta F, Madruga J, Reuter T, Newman T, Small CB, Lombaard J, Grinsztejn B, Dorey D, Underwood M, Griffith S, Min S; extended SAILING Study Team.

Lancet. 2013 Aug 24;382(9893):700-8. doi: 10.1016/S0140-6736(13)61221-0. Epub 2013 Jul 3. Erratum in: Lancet. 2014 Jan 4;383(9911):30.

PMID:
23830355
2.

Nevirapine-associated toxicity in clinical practice in Buenos Aires, Argentina.

Bottaro EG, Huberman MJ, Iannella Mdel C, Vesperoni FA, Scapellato PG, Errea S, Antonelli L, Cassetti LI.

J Int Assoc Physicians AIDS Care (Chic). 2010 Sep-Oct;9(5):306-12. doi: 10.1177/1545109710376250.

PMID:
20923955
3.

Good neurocognitive performance measured by the international HIV dementia scale in early HIV-1 infection.

Lopardo GD, Bissio E, Iannella Mdel C, Crespo AD, Garone DB, Cassetti LI.

J Acquir Immune Defic Syndr. 2009 Dec 1;52(4):488-92. doi: 10.1097/QAI.0b013e3181b06348.

PMID:
19654553
4.

[Cytomegalovirus polyradiculomyelopathy in AIDS].

Jayaweera DT, Cassetti LI, Espinoza L, Lopardo GD, Hansman-Whiteman ML, Scerpella EG.

Medicina (B Aires). 1998;58(2):135-40. Spanish.

PMID:
9706245
Format
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk